Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treat- ment of cancer using brachytherapy.
Brachytherapy is a form of radiotherapy that treats cancer by irra- diation from a short distance. Two different forms of brachytherapy are used today: permanent and temporary brachytherapy. In perma- nent brachytherapy, a small radioactive source is implanted in the body, while in temporary brachytherapy, the radioactive source is placed directly inside or close to the site of the tumour for a limited and defined period.
Eckert & Ziegler BEBIG offers a complete portfolio of brachytherapy products, which comprises the HDR afterloader, MultiSource®, the permanent prostate implants so called seeds in a loose (IsoSeed®) and stranded form (IsoCord®), as well as ophthalmic applicators for the treatment of eye tumours. Eckert & Ziegler BEBIG is also the only provider worldwide of the miniaturised cobalt Co-60 source used in the HDR afterloading systems.
The company’s products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.
06.06. - 08.06.2013
ESTRO Teaching Course: Brachytherapy for prostate cancer
Cologne, Germany